NEO NeoGenomics Laboratories, Inc.
$16.51 -13.70%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-13.70%
YTD
+82.80%
P/E
—
P/B
1.82
ROE
-6.3%
Div yield
—
Beta
0.95
Market cap
$2.3B
RSI (14)
40
Next earnings
Oct 26, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$20.00
Close
$16.51
VWAP (n/a)
—
Day high
$20.15
Day low
$16.47
Volume
5.1M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Why NeoGenomics (NEO) Stock Is Up Today
Yahoo Finance · Oct 6
Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive
Yahoo Finance · Oct 6
NeoGenomics Sinks 12% on CEO Succession Plan Despite Revenue Beat
Yahoo Finance · Oct 6
Did Strong Q3 Outlook and New CEO Plan Just Shift NeoGenomics' (NEO) Investment Narrative?
Yahoo Finance · Oct 6
NeoGenomics stock falls on CEO transition announcement
Investing.com · Oct 5
NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
Yahoo Finance · Oct 5
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 5, 2026 View → 8-K Aug 11, 2026 View → 10-Q Jul 28, 2026 View → 8-K Jul 28, 2026 View → 8-K Jul 20, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell NEO. Try it in the Lab to size a position and see the risk.